Efficacy and safety of arterial FOLFOX chemotherapy plus anti-PD-(L)1 immunotherapy as a first-line treatment for unresectable intrahepatic cholangiocarcinoma: a propensity score matching analysis
HAIC+αPD-(L)1 had acceptable toxic effects and might improve outcomes compared to SYS+αPD-(L)1 as a first-line treatment for patients with uICC.
Authors
- Jie Xu (ORCID: https://orcid.org/0009-0005-8658-5744)
- Xi Cai
- Jiong-Liang Wang
- Xiongying Jiang (ORCID: https://orcid.org/0000-0003-4488-9326)
- S. Zhong
- Yue Hu (ORCID: https://orcid.org/0000-0002-9191-7433)
- Qifeng Chen (ORCID: https://orcid.org/0000-0001-8998-3450)
- Jun‐Zhe Yi (ORCID: https://orcid.org/0000-0002-0588-2060)
- Ning Lyu (ORCID: https://orcid.org/0000-0002-8254-1040)
- Gen-Jun Tan
- Song Chen (ORCID: https://orcid.org/0000-0002-5276-3953)
- Ming Zhao (ORCID: https://orcid.org/0009-0000-5361-0361)
Institutions
- Sun Yat-sen University (CN)
- Sun Yat-sen University Cancer Center (CN)
Publication Details
- Journal
- Journal of Gastrointestinal Oncology
- Published
- 2025-02-01
- DOI
- https://doi.org/10.21037/jgo-24-552
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00